Industry News
Pancreatic Cancer Risk May Be Reduced By High Dietary Antioxidant Intake
Jul 23, 2012
Individuals can significantly reduce their risk of developing pancreatic cancer by increasing their dietary intake of the antioxidant vitamins C, E, and selenium, say researchers who are leading the Norfolk arm of the European Prospective Investigation of Cancer (EPIC) study... Read More
Pancreatic Cancer Risk May Be Reduced By High Dietary Antioxidant Intake
Jul 23, 2012
Individuals can significantly reduce their risk of developing pancreatic cancer by increasing their dietary intake of the antioxidant vitamins C, E, and selenium, say researchers who are leading the Norfolk arm of the European Prospective Investigation of Cancer (EPIC) study... Read More
Localized Prostate Cancer: Removal No Better Than Observation, Study
Jul 23, 2012
A large study that followed men across the US diagnosed with localized prostate cancer for over 10 years found they lived just as long whether they had surgery to remove the prostate or underwent observation. The researchers say their findings support observation over surgery for men with localized prostate cancer, especially if it is low-risk... Read More
Afinitor (Everolimus) Combo For Breast Cancer Approved By FDA
Jul 23, 2012
The FDA has approved Afinitor (everolimus) in combination with Aromasin (exemestane) for the treatment of some postmenopausal females with advanced hormone-receptor positive, HER2-negative breast cancer... Read More
Genetic Mutations Identified That Cause Common Childhood Brain Tumors
Jul 23, 2012
Researchers at the Stanford University School of Medicine and Lucile Packard Children's Hospital have identified several gene mutations responsible for the most common childhood brain tumor, called medulloblastoma, adding evidence to the theory that the diagnosis is a group of genetically distinct cancers with different prognoses... Read More
Melanoma-Driving Genetic Changes Caused By Sun Damage
Jul 23, 2012
It's been a burning question in melanoma research: Tumor cells are full of ultraviolet (UV)-induced genetic damage caused by sunlight exposure, but which mutations drive this cancer? None have been conclusively tied to melanoma. The sheer abundance of these passenger mutations has obscured the search for genetic driver mutations that actually matter in melanoma development and progression... Read More
Melanoma-Driving Genetic Changes Caused By Sun Damage
Jul 23, 2012
It's been a burning question in melanoma research: Tumor cells are full of ultraviolet (UV)-induced genetic damage caused by sunlight exposure, but which mutations drive this cancer? None have been conclusively tied to melanoma. The sheer abundance of these passenger mutations has obscured the search for genetic driver mutations that actually matter in melanoma development and progression... Read More
Testing IDO Inhibitors As A Treatment For Cancer: Preclinical Data Support Ongoing Clinical Trials
Jul 23, 2012
Inhibitors of indoleamine 2,3-dioxygenase (IDO) are being assessed in clinical trials as a potential treatment for recurrent or refractory solid tumors... Read More
Placenta-Derived ECFCs Offer Great Promise For Stem Cell Therapy
Jul 23, 2012
A study comparing whether endothelial colony-forming cells (ECFCs) derived from human placenta or those derived from human umbilical cord blood are more proliferative and better for forming new blood vessels has found that ECFCs derived from human placenta are more vasculogenic... Read More
Placenta-Derived ECFCs Offer Great Promise For Stem Cell Therapy
Jul 23, 2012
A study comparing whether endothelial colony-forming cells (ECFCs) derived from human placenta or those derived from human umbilical cord blood are more proliferative and better for forming new blood vessels has found that ECFCs derived from human placenta are more vasculogenic... Read More
Previous Page Next Page